Provided by Tiger Trade Technology Pte. Ltd.

Verastem

7.55
+0.23003.14%
Post-market: 7.45-0.1000-1.32%19:30 EDT
Volume:1.73M
Turnover:13.30M
Market Cap:683.75M
PE:-3.13
High:7.91
Open:7.58
Low:7.54
Close:7.32
52wk High:10.82
52wk Low:3.43
Shares:90.56M
Float Shares:70.57M
Volume Ratio:0.83
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4143
EPS(LYR):-3.0223
ROE:-471.16%
ROA:-49.59%
PB:13.68
PE(LYR):-2.50

Loading ...

Press Release: Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026

Dow Jones
·
Jul 23

Verastem Oncology to Report Q2 2026 Financial Results in Conference Call

Reuters
·
Jul 23

Verastem doses first patient in TARGET-D 202 Phase 2 trial

TIPRANKS
·
Jul 23

Verastem Oncology Doses First Patient in Target-d 202 Phase 2 Registration-directed Trial of Vs-7375 for Kras G12d-mutated Advanced Non-small Cell Lung Cancer

THOMSON REUTERS
·
Jul 23

These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why

Benzinga_recent_news
·
Jul 22

Verastem’s KRAS G12D Trial Targets a New Niche in Colorectal Cancer

TIPRANKS
·
Jul 18

Verastem is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 08

RBC Capital Adjusts Verastem Price Target to $14 From $15, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Verastem Oncology Grants 399,750 Rsus, Sets New-hire Stock Option Exercise Price at $4.1

Reuters
·
Jul 03

Verastem Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 03

Verastem is Maintained at Buy by BTIG

Dow Jones
·
Jul 03

Cardiff, Verastem, Fluence, Quantum-Si, Opera Insider Shock

TIPRANKS
·
Jun 27

Top Verastem Executives Quietly Cash Out in Fresh Stock Moves

TIPRANKS
·
Jun 25

Verastem's VS-7375 Update Reiterates Potential in US Patients, RBC Says

MT Newswires Live
·
Jun 24

Verastem (VSTM) Gets a Buy from Alliance Global Partners

TIPRANKS
·
Jun 24

Analysts Are Bullish on These Healthcare Stocks: Palvella Therapeutics (PVLA), Verastem (VSTM)

TIPRANKS
·
Jun 24

Verastem Price Target Maintained with a $18.00/share by HC Wainwright & Co.

Dow Jones
·
Jun 24

Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Verastem (VSTM) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jun 24

BRIEF-Versus-7375 Demonstrates Clinical Activity With A Favorable Safety And Tolerability Profile In Target-D 101

Reuters
·
Jun 24

Verastem Advances VS-7375 with Promising Early Trial Data

TIPRANKS
·
Jun 24